SCHEMBL8618485

SCHEMBL8618485

C/C(=C\CCCI)CCCCc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LSS P48449 2/20 0.48
MAPT P10636 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
ALOX5 P09917 3/20 0.43
ALDH1A1 P00352 2/20 0.42
HPGD P15428 1/20 0.42
ALOX15 P16050 1/20 0.42
ALOX12 P18054 1/20 0.42
CASP1 P29466 1/20 0.42
HSD17B10 Q99714 1/20 0.42
TRPV1 Q8NER1 2/20 0.41
HDAC1 Q13547 2/20 0.41
HDAC2 Q92769 2/20 0.41
FAAH O00519 3/20 0.40
CES1 P23141 3/20 0.40
HDAC3 O15379 1/20 0.40
MAPK1 P28482 1/20 0.40
ADRA1A P35348 1/20 0.40
HDAC4 P56524 1/20 0.40
SLC6A3 Q01959 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8621505 1.00 LSS (0.48) LSSMAPTRXFP1ALOX5ALDH1A1
SCHEMBL8626252 0.90 TRPV1 (0.46) LSSALDH1A1HPGDALOX15ALOX12
SCHEMBL8626255 0.90 TRPV1 (0.46) LSSALDH1A1HPGDALOX15ALOX12
SCHEMBL8624956 0.86 LSS (0.49) LSSMAPTRXFP1ALOX5ALDH1A1
SCHEMBL8624953 0.86 LSS (0.49) LSSMAPTRXFP1ALOX5ALDH1A1
SCHEMBL15796944 0.82 MAPT (0.52) LSSMAPTRXFP1ALOX5ALDH1A1
SCHEMBL8623445 0.81 CNR1 (0.37) LSSALDH1A1HPGDHSD17B10TRPV1
SCHEMBL8623439 0.81 CNR1 (0.37) LSSALDH1A1HPGDHSD17B10TRPV1
SCHEMBL10971010 0.79 MAPT (0.63) LSSMAPTRXFP1ALOX5HSD17B10
SCHEMBL10971007 0.79 MAPT (0.63) LSSMAPTRXFP1ALOX5HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5712396-A PHOSPHONOSULFONATE COMPOUNDS USED FOR INHIBITING CHOLESTEROL BIOSYNTHESIS AND ATHEROSCLEROSIS MAGNIN DAVID R (US) 1998-01-27 US disclosed
US-5567841-A ANTICHOLESTEROL AGENT BRISTOL-MYERS SQUIBB COMPANY (US) 1996-10-22 US disclosed
US-5470845-A Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia BRISTOL-MYERS SQUIBB COMPANY (US) 1995-11-28 US disclosed
EP-0513761-A2 Bisphosphonate squalene synthetase inhibitors E.R. SQUIBB & SONS, INC. (US) 1992-11-19 EP disclosed
US-5157027-A Anticholesterol agents E. R. SQUIBB & SONS, INC. (US) 1992-10-20 US disclosed